Literature DB >> 11722587

Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis.

S Balabanov1, U Zimmermann, C Protzel, C Scharf, K J Klebingat, R Walther.   

Abstract

To identify tumour-related enzyme alterations we have used 2D-gels to analyse the proteome from dissected malignant and benign kidney areas from patients with clear-cell-type renal carcinoma. The expression of 12 proteins was diminished in tumour. Four proteins were characterized by mass spectrometry and were identified as enoyl-CoA hydratase, alpha-glycerol-3-phosphate dehydrogenase, aldehyde dehydrogenase 1 and aminoacylase-I.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722587     DOI: 10.1046/j.0014-2956.2001.02546.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

Authors:  Travis Young; Fang Mei; Jinsong Liu; Robert C Bast; Alexander Kurosky; Xiaodong Cheng
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

3.  Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?

Authors:  Barbara Seliger; Simon Jasinski; Sven P Dressler; Francesco M Marincola; Christian V Recktenwald; Ena Wang; Rudolf Lichtenfels
Journal:  J Proteome Res       Date:  2011-01-07       Impact factor: 4.466

4.  Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.

Authors:  Barbara Seliger; Sven P Dressler; Ena Wang; Roland Kellner; Christian V Recktenwald; Friedrich Lottspeich; Francesco M Marincola; Maja Baumgärtner; Derek Atkins; Rudolf Lichtenfels
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

5.  Protein expression profiling in the spectrum of renal cell carcinomas.

Authors:  Vladimir A Valera; Elsa Li-Ning-T; Beatriz A Walter; David D Roberts; W M Linehan; Maria J Merino
Journal:  J Cancer       Date:  2010-10-14       Impact factor: 4.207

6.  Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis.

Authors:  Jeong Seok Hwa; Hyo Jin Park; Jae Hun Jung; Sung Chul Kam; Hyung Chul Park; Choong Won Kim; Kee Ryeon Kang; Jea Seog Hyun; Ky Hyun Chung
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 7.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

8.  Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.

Authors:  Heike Junker; Simone Venz; Uwe Zimmermann; Andrea Thiele; Christian Scharf; Reinhard Walther
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

9.  YueF overexpression inhibits cell proliferation partly through p21 upregulation in renal cell carcinoma.

Authors:  Hsuan-Wei Huang; Jian-Ping Peng; Jie Zhang
Journal:  Int J Mol Sci       Date:  2011-04-11       Impact factor: 5.923

10.  A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism.

Authors:  Ren Liu; Yuanfa Feng; Yulin Deng; Zhihao Zou; Jianheng Ye; Zhiduan Cai; Xuejin Zhu; Yingke Liang; Jianming Lu; Hui Zhang; Yong Luo; Zhaodong Han; Yangjia Zhuo; Qingling Xie; Chi Tin Hon; Yuxiang Liang; Chin-Lee Wu; Weide Zhong
Journal:  J Exp Clin Cancer Res       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.